Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Approves Lactose-Free Formulation of Antispasmodic/Anticholinergic, Pamine (Methoscopolamine) FAIRFIELD, NJ -- June 28, 2001 -- Bradley Pharmaceuticals, Inc. announced today that the Food and Drug Administration (FDA) approved a lactose-free formulation of Pamine® (methscopolamine bromide), the company's fast-growing antispasmodic/anticholinergic therapy. Although the original Pamine formula contained only a very small amount of lactose that would not have adversely affected most lactose-intolerant patients, Bradley chose to create this new formulation to ensure that this therapy was the best possible product. In a recent survey, gastroenterologists estimate that 10 to 40 percent of their patients with gastrointestinal (GI) hypermotility are lactose-intolerant. It is estimated that between 30 and 50 million Americans are lactose-intolerant, and some studies report that incidences of lactose intolerance are very high in certain ethnic populations. According to these reports, as many as 75 percent of African-Americans and 90 percent of Asians may be lactose-intolerant. Daniel Glassman, President and CEO of Bradley Pharmaceuticals, Inc., stated, "We have improved the formulation of Pamine because we recognize the special needs of lactose-intolerant patients. Our goal is to reduce the possibility of lactose interfering with the relief Pamine can provide. New and improved Pamine offers lactose-intolerant patients the safest and most effective antispasmodic/anticholinergic that we can make." SOURCE: Bradley Pharmaceuticals, Inc. E-mail this page to a friend or colleague! To print, use this version